ABSTRACT. The sequence of reactions involved in plasmalogen biosynthesis has been evaluated in cultured fibroblasts of patients with the cerebrohepatorenal syndrome. A double-label, double-substrate incubation using [l-'4C] hexadecanol and 1-0-[9', 10'-3H]hexadecylglycerol was performed to monitor the relative rates of peroxisomal and microsomal biosynthesic steps. [l4Cj radioactivity associated with 1'-alkenyl groups of plasmalogens was found to be drastically reduced in fibroblasts of affected patients whereas [3H] incorporation was apparently normal. This finding is specific for cerebrohepatorenal syndrome fibroblasts since cell lines of patients with childhood adrenoleukodystrophy and neuronal ceroidlipofuscinosis utilized the lipid precursors of plasmalogen biosynthesis a t normal rates. The results show that the defect in plasmalogen synthesis in the cerebro-hepato-renal syndrome is restricted to the peroxisomal steps. The finding of normal microsomal biosynthetic steps was exploited to devise a novel diagnostic assay in fibroblasts and amniocytes based on the comparison of [3H/14C] isotope ratios within aldehydes released from plasmalogens by acid hydrolysis. The procedure can be completed with a minimal amount of cells since it renders quantitative analyses unnecessary. Therefore, this technique appears ideally suited for the sensitive and safe prenatal diagnosis of the cerebro-hepato-renal syndrome. (Pediatr Res 19: 930-933,1984) Abbreviations ALD, adrenoleukodystrophy CHRS, cerebro-hepato-renal syndrome DHAP, dihydroxyacetonephosphate NCL, neuronal ceroidlipofuscinosis VLCFA, very-long-chain fatty acids function, severe hypotonia, psychomotor retardation, and dysmorphic features ( I , 2).
This syndrome is accompanied by a variety of biochemical disturbances such as hyperpipecolic acidemia, hepatic and cerebral glycogen storage (2), elevated VLCFA (3, 4), abnormal bile acids (5, 6), dicarboxylic aciduria, and diminished levels of plasmalogens (7, 8) . Most of the abnormalities may relate to the absence of peroxisomes and/or to severely impaired mitochondrial functions in patients (9, 10) .
Since the infants usually die within the 1st yr of life, an early and precise biochemical diagnosis is important for providing adequate genetic counseling. The study of VLCFA, particularly of hexacosanoic acid (C26:O) and hexacosenoic acid (C26:I) in amniotic fluid and in cultured amniocytes has been proposed for prenatal diagnosis (3, 1 1). Alternately, diagnosis based on measurement of DHAP-acyltransferase-the first enzyme in the pathway leading to plasmalogen biosynthesis (12)-has been suggested (1 3). However, the complete biosynthetic pathway leading to plasmalogens has not been investigated so far in CHRS. In this study we used [l-'4C]hexadecanol and [9',10'-3H] hexadecylglycerol to investigate both the peroxisomal and microsomal steps of plasmalogen biosynthesis. The finding of normal microsoma1 steps of plasmalogen formation was exploited to devise a novel technique for the biochemical diagosis of CHRS.
MATERIALS A N D METHODS
[I -'4C]hexadecanol was purchased from Amersham (England) and diluted with hexadecanol to a specific activity of 1 1.4 mCi/ mmol. [9', 10'-3H]-sn-hexadecylglycerol (specific radioactivity 5.5 mCi/mmol) was prepared by chemical synthesis (14) (on request it is available from the authors). Unlabeled phospholipid standards were prepared in our laboratory by conventional chromatographic procedures.
Culture medium, enzyme solutions, and additions for the culture media were from Serva (Heidelberg, FRG), bovine serum albumin from Armour Pharmaceutical Co. (Phoenix, AZ). All The CHRS (Zellweger) is a rare autosomal recessive disorder, other reagents were of analytical grade and obtained from comclinicallv characterized by abnormalities in liver and kidney mercial sources. All other cell strains were initiated at the Paediatric Tissue Culture Unit, University of Graz, Medical School. Control skin biopsies were taken on the occasion of minor surgery (herniotomia) from otherwise healthy children. Diagnosis of ALD was based on neurological findings and was confirmed by increased C2(,0 fatty acid levels in leukocytes and fibroblasts (1 5). Patients with NCL were diagnosed by the typical clinical and ultrastructural findings (16) and the patient with CHRS was recognized by the typical clinical characteristics (2) and by the presence of hyperpipecolic acidemia.
Stock cultures of human fibroblasts were grown in Eagle's basal medium supplemented with Earle's salts, 10% fetal calf serum, and 2 m M glutamine as previously described (17) . Subcultures, initiated with 1 x 10"ells in 60-mm dishes (Falcon Plastics, CA), were grown to confluency and the standard medium was renewed the day before experiments were carried out. Analyses. Fibroblast pellets were disintegrated by sonication in I ml of water and total cellular lipids were then extracted according to Folch ct al. (18) . The plasmalogen content of the phosphatidylethanolamine and phosphatidylcholine fractions was determined by two-dimensional thin-layer chromatography (1 9). Silica gel P F 60 plates were first developed in chloroformmethanol-water (65:25:4, by vol), dried, exposed to fumes of concentrated HCI, and finally developed in the second dimension with the same solvent. Phospholipid phosphorus was quantitated according to the procedure of Rouser et ul. (20) . When radioactively labeled substrates were supplemented to the cultures, the separation of labeled aldehydes released from plasmalogens by acid catalyzed hydrolysis was accomplished by thin-layer chromatography using a dual-development technique according to Paltauf (2 1). Aliquots of the lipid extracts were applied to thinlayer plates coated with 0.5 m m silica gel H (Merck, Darmstadt, FRG). To each spot 0.2 mg of ox brain phosphatidylethanolamine and 0.2 mg hexadecylglycerol were added to carriers. The plate was first developed with diethylether/H20 (100/0.25, by vol) to remove radioactively labeled neutral lipids, then exposed to HCI fumes for 10 min. and developed twice with light petroleum/diethylether (9515, by vol) to a distance of 10 cm from the origin. Spots corresponding to aldehydes were visualized by brief cxposurc to iodine vapor, signed, and decolorized under a stream of air. Radioactivity was measured after the spots were transferred directly into counting vials, using a xylene-based scintillation cocktail.
Isolation of fatty acids, esterification, and analysis of fatty acid methylesters was performed as reported previously (1 5).
RESULTS AND DISCUSSION
Recent findings demonstrate that CHRS fibroblasts exhibit abnormally elevated levels of VLCFA similar to those found in ALD (4. 15. 22) . In this study (Table 1) * Total lipids extracted from fibroblasts were analyzed by two-dimensional reaction thin-layer chromatography as described in "Materials and Methods." Only the data obtained for the ethanolamine glycerophospholipid fraction are shown in Table 2 since the plasmalogen content of other phospholipid classes was negligibly low.
t Glycerophosphoethanolamine.
$ Control.
ALD fibroblasts as well. The higher C260/C22:0 ratio in CHR:S than in ALD cells was due to the relatively low C22:0 levels in CHRS fibroblasts (data not shown). The VLCFA levels and C26:0/ C22:0 ratios in fibroblasts of patients with NCL were within the normal range. It has been proposed that ALD and CHRS share some impaired peroxisomal functions although the exact mechanisms underlying the VLCFA accumulations in these two diseases appear to be different (3) .
Plasmalogen deficiency in tissues of CHRS is also suspected to be due to peroxisomal abnormalities (7, 8) . Recent experiments have shown (13) that acyl coenzyme A:dihydroxyacetonephosphate acyltransferase is virtually absent from CHR:S cells (brain, liver, and fibroblasts). So far, however, the specificity of this finding has not been systematically evaluated. For example, a virtual absence of plasmalogens in brain extracts froni patients with NCL has been reported (16) . Therefore we determined total plasmalogen levels in cultured fibroblasts of patients with CHRS, ALD, and NCL (Table 2) . Phospholipid analyses o'f fibroblast lipid extracts revealed a pronounced reduction of total Cell strains of both diseases showed normal utilization of the two precursors of plasmalogen biosynthesis. This is consistent with the hypothesis that impaired ether lipid biosynthesis is specific for CHRS.
We further show by this technique that ether lipid biosynthesis in fibroblasts of obligate heterozygotes is in the range of controls. This is in agreement with the demonstration of normal acyl CoA DHAP acyltransferase activity in CHRS heterozygote fibroblasts ( 13) . The failure to demonstrate a simple gene dosage relationship suggests that the basic defect in CHRS resides rather in the assembly of functional peroxisomes than in a specific enzyme involved in ether lipid synthesis.
A specific and reliable biochemical method for the diagnosis of CHRS is essential to differentiate this disease from other causes of the "floppy infant syndrome." For practical purposes, the double-label, double-substrate technique reported herein offers several advantages. Since microsomal plasmalogens synthesis from alkyl glycerol precursors is normal in C H R S , [3H]hexadecylglycerol can be utilized to serve as an internal reference. Diagnosis of CHRS can be established simply by comparing the ['H/I4C] isotope ratio within aldehydes released from plasmalogens by acid hydrolysis (Table 3 ). This renders quantitative analyses (c'.g. of lipids, enzyme activities, or cell protein) unnecessary and allows diagnosis from a limited amount of cells. [3H/ I4C] isotope ratios similar to those shown in Table 3 The calculation ofthe [3H/14C] isotope ratio appears to provide a high degree of sensitivity due to the great difference between disease and control (1 5-to 60-fold). While the existing techniques for the diagnosis of a CHRS child or fetus appear to work well the method described herein may be a useful supplement especially under conditions when high diagnostic sensitivity and safety is mandatory. 
